4.6 Article

Diagnosed Mild Cognitive Impairment Due to Alzheimer's Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Longitudinal Assessment of A beta and Cognition in Aging and Alzheimer Disease

Victor L. Villemagne et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Alzheimer's Disease Neuroimaging Initiative (ADNI) Clinical characterization

R. C. Petersen et al.

NEUROLOGY (2010)

Article Clinical Neurology

Comparing predictors of conversion and decline in mild cognitive impairment

S. M. Landau et al.

NEUROLOGY (2010)

Article Geriatrics & Gerontology

PET imaging of amyloid deposition in patients with mild cognitive impairment

Anton Forsberg et al.

NEUROBIOLOGY OF AGING (2008)

Article Clinical Neurology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

WE Klunk et al.

ANNALS OF NEUROLOGY (2004)

Article Chemistry, Medicinal

Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

CA Mathis et al.

JOURNAL OF MEDICINAL CHEMISTRY (2003)